Medical myths, especially those rooted in outdated science, tend to linger far beyond their expiration date. Cardiovascular disease (CVD), the world’s leading cause of death, has been surrounded by such myths — the belief that heart disease is an inevitable part of ageing, that cholesterol and blood pressure naturally rise as we grow older, or that heart attacks strike unpredictably, even in the absence of identifiable risk factors.
Over the last two decades, large-scale epidemiological studies and meta-analyses have debunked these dogmas. Cardiovascular disease, it turns out, is not the unavoidable consequence of ageing but largely a result of modifiable lifestyle factors.
The Landmark INTERHEART Study — And Beyond
The 2004 INTERHEART study, a massive case-control study involving over 52 countries, revealed that over 90% of the risk for a first heart attack is attributable to nine modifiable risk factors — smoking, unhealthy diet, lack of physical activity, abdominal obesity, high blood pressure, diabetes, alcohol consumption, psychosocial factors, and abnormal lipids (Yusuf et al., The Lancet, 2004).
These findings have been repeatedly confirmed. In 2021, a comprehensive meta-analysis published in The Lancet Global Health reaffirmed that modifiable risk factors remain the predominant contributors to CVD worldwide, regardless of region or economic status (GBD 2019 Risk Factors Collaborators, Lancet Global Health, 2021).
Prospective studies from Harvard, including the Nurses’ Health Study and the Health Professionals Follow-Up Study, showed that adherence to five simple lifestyle habits — not smoking, maintaining a healthy weight, eating a high-quality diet, engaging in regular physical activity, and moderate alcohol intake — is associated with an 86% lower risk of coronary heart disease in women and 81% in men (Chiuve et al., Circulation, 2012).
Similarly, the EPIC Study in Europe found that healthy lifestyle adherence could reduce heart attack incidence by over 80% and also dramatically lower the risk of stroke, diabetes, and cancer (European Journal of Epidemiology, 2020).
The Drug vs. Lifestyle Paradox
Pharmacological therapies like statins and antihypertensives do reduce cardiovascular risk — but by about 20–30% individually, according to pooled analyses (JAMA, 2022). Even combined therapy does not approach the risk reduction achieved by lifestyle modification.
For example, in a 2023 BMJ meta-analysis, statins reduced cardiovascular events by about 27% on average, but combining statins with lifestyle changes could reduce risk by up to 78% (BMJ, 2023). This echoes findings from earlier studies like Chiuve et al. (2006), which emphasized that even those on medications could slash their risk substantially through healthy living.
New Evidence on Inflammation and Lifestyle
More recent insights emphasise chronic inflammation as a critical player in heart disease. The CANTOS trial (2017) demonstrated that reducing inflammation independently of cholesterol could lower cardiovascular risk (Ridker et al., NEJM, 2017). Lifestyle practices — including plant-based diets, physical activity, adequate sleep, and stress management — are now recognized as potent anti-inflammatory interventions (Franco et al., Nutrients, 2022).
Genetic Risk and the Power of Lifestyle
One of the most significant advances in recent years has been in understanding gene-lifestyle interactions. The 2016 study published in NEJM showed that individuals with high genetic risk for heart disease could reduce their risk by nearly 50% through healthy lifestyle choices (Khera et al., NEJM, 2016). This effectively nullifies the fatalistic narrative that genes doom us to disease.
Why Isn’t This Common Practice Yet?
Medicine is slow to change. As renowned cardiologist Dr. Robert Califf (former FDA Commissioner) pointed out, there is often a 17-year lag between research evidence and clinical practice. This gap can have dire consequences when it comes to preventing the world’s leading killer.
Even in 2024, surveys of practicing cardiologists reveal a tendency to over-rely on medication while underemphasising lifestyle counseling, largely due to systemic barriers like time constraints and reimbursement models (Journal of the American College of Cardiology, 2024).
The Takeaway: Lifestyle First, Medication as Adjunct
• Lifestyle interventions — plant-forward diet, exercise, weight control, non-smoking, sleep, and stress management — can potentially eliminate up to 90% of heart disease risk.
• Medications have a role but should serve as complements, not substitutes, for healthy living.
• The earlier the intervention, the greater the benefit, but it’s never too late to start.
References
• Yusuf S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study). The Lancet. 2004;364(9438):937-952.
• GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis. Lancet Global Health. 2021;10(6):e825–e841.
• Chiuve SE et al. Healthy lifestyle in the primary prevention of coronary heart disease among men. Circulation. 2012;125(7):791-799.
• Khera AV et al. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. NEJM. 2016;375:2349-2358.
• Ridker PM et al. Anti-inflammatory therapy with canakinumab for atherosclerotic disease. NEJM. 2017;377(12):1119-1131.
• Franco OH et al. Lifestyle and Inflammation. Nutrients. 2022;14(8):1712.
• BMJ 2023 Clinical Evidence Series: Comparative effectiveness of statins, lifestyle changes, and their combination.
Give a Reply